LCM
BCAB icon

Laurion Capital Management’s BioAtla BCAB Stock Holding History

Laurion Capital Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,852
Closed -$784K – 605
2023
Q1 		$784K Hold
5,852
– – 0.01% 312
2022
Q4 		$2.41M Hold
5,852
– – 0.01% 304
2022
Q3 		$2.25M Hold
5,852
– – 0.01% 322
2022
Q2 		$834K Buy
+5,852
New +$931K 0.01% 304
2021
Q2 		– Sell
-400
Closed -$1.02M – 719
2021
Q1 		$1.02M Hold
400
– – 0.01% 494
2020
Q4 		$680K Buy
+400
New +$669K 0.01% 450

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Laurion Capital Management's BCAB Position: Q2 2023 in Review

Laurion Capital Management sold out of BioAtla (BCAB) in Q2 2023, closing a stake of 5,852 shares — an estimated $784K sold.

Laurion Capital Management first reported a position in BCAB in Q4 2020 and held it in 6 quarters. The position peaked at $2.41M in Q4 2022. 87 funds tracked by Wall St. Rank hold BCAB as of Q2 2023.

  • Laurion Capital Management reported no remaining BioAtla position as of Q2 2023 after selling out during the quarter.
  • Laurion Capital Management sold 5,852 BioAtla shares in Q2 2023, an estimated $784K.
  • Laurion Capital Management first reported a position in BioAtla in Q4 2020 and held it in 6 quarters.
  • Laurion Capital Management's BioAtla position peaked at $2.41M in Q4 2022.
  • 87 funds tracked by Wall St. Rank held BioAtla as of Q2 2023.

Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.